InvestorsHub Logo
Followers 89
Posts 17486
Boards Moderated 0
Alias Born 09/06/2006

Re: Single Stock post# 698381

Saturday, 06/15/2024 9:18:29 AM

Saturday, June 15, 2024 9:18:29 AM

Post# of 705915

25% of NVCR revenue was EMEA , which 2022 vs 2023 dropped 2.2%, this year it will show a far greater drop as UK for sure have stopped prescribing it.


Q1 2024 showed solid growth in the EU over Q1 2023 thanks to the launch in France.

As far as UK, neither company has material revenue in the UK, and neither will this year.

BTW, you might sometimes try actually reading the Form 4s. Almost all of what you are seeing is their pay package which includes stock and has programed selling to offset taxes.
Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News